Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061308
Status:
COMPLETED
Last Update Posted:
2017-06-09
First Post:
2003-05-23
Brief Title:
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian Fallopian Or Peritoneal Cancer
Sponsor:
Organization:
GlaxoSmithKline